FT

Bristol-Myers Squibb to pay $13.1bn for heart treatment maker

Photo of Financial Times Financial Times
0 Less than a minute

Deal to buy MyoKardia is US company’s first major acquisition since Celgene last year

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

US gun and ammunition sales surge ahead of election

Coronavirus latest: Renminbi reaches 2-year high vs greenback on China’s economic recovery

Credit Suisse to add $850m to US provisions

Alex Karp, unconventional purveyor of powerful surveillance tools

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button